The Effect of CORT118335 on Olanzapine-Induced Weight Gain

Clinical trial NCT03877562 · COMPLETED

Trial details

NCT number: NCT03877562
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Antipsychotic-induced Weight Gain

Start date: 2019-04-01
Primary completion: 2020-03-13
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.